What Bright Way Group does

Velpharm Group (Bright Way Group) is a Russian pharmaceutical manufacturing company that develops, produces, and distributes generic medications and vital essential medicines for the Russian domestic market. The group operates through a multi-subsidiary structure: ООО «Велфарм» (Velpharm) serves as the parent company, Velpharm-M operates manufacturing facilities including a new plant opened in Zelenograd in October 2022, Veltrade handles trading and distribution, Velpharm MC functions as the management company, and Velpharm Global (operating under the Biomialvel brand) pursues international operations. Production is based at two sites in Kurgan and Zelenograd, with plans announced in September 2022 for a world-class pharmaceutical cluster in Zelenograd.

The company's product portfolio includes 12+ marketed preparations, 23+ vital essential medicines, 43+ preparations in registration, and 27+ in development, concentrated in one core therapeutic area. The group offers contract manufacturing, licensing production, and private label (СТМ) programs for pharmacy chains, alongside direct supply to hospitals, clinics, and medical facilities. Technical capabilities center on modern pharmaceutical manufacturing technologies rather than digital or AI-driven differentiation.

Velpharm generates revenue primarily through one-time B2B pharmaceutical product sales contracts with pharmacy chains, healthcare institutions, and distributors across Russia. The go-to-market motion is enterprise field sales targeting pharmacy networks and institutional buyers. The company's strategy is explicitly aligned with the Russian Federation's national pharmaceutical policy objective to increase domestic production share to 50% by 2030, and it was recognized as a 2025 laureate of the Government Prize of the Russian Federation in the Field of Quality, reinforcing its position as a favored domestic manufacturer under the import substitution framework.

Name

Bright Way Group

Legal name

ООО «Велфарм»

Website

https://brway.ru

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Velpharm Group (Bright Way Group) is a Russian pharmaceutical manufacturer producing generic and vital essential medicines for pharmacy chains and healthcare institutions, operating manufacturing facilities in Kurgan and Zelenograd with private label and contract manufacturing services.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

Keywords

• Pharmaceutical manufacturing
• Drug production
• Contract manufacturing
• Essential medicines
• Private label pharma

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Drug Sales: Revenue generated from manufacturing and selling pharmaceutical preparations to pharmacy chains, healthcare institutions, and distributors. Product portfolio includes 12+ preparations, 23+ vital essential medicines, 43+ preparations in registration phase, and 27+ in development.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Velpharm Group is a Russian pharmaceutical manufacturing company that produces modern, high-quality, and affordable medicinal products, including essential medicines, with a portfolio of 12+ marketed preparations, 23+ vital essential medicines, 43+ preparations in registration, and 27+ under development. Beyond its own branded pharmaceutical production, the group offers contract manufacturing, licensing production, and private label (СТМ) projects for pharmacy chains, operating production facilities in Kurgan and at the newly opened Velpharm-M plant.

Product overview

Velpharm Group (Велфарм Группа) is a Russian pharmaceutical manufacturing company comprising multiple subsidiaries: Velpharm (parent company focused on drug production and development), Velpharm-M (manufacturing facility with a new plant opened in 2022 in Zelenograd), Veltrade (distribution/trade subsidiary), Velpharm MC (management company), and Velpharm Global/Biomialvel (international operations subsidiary). The group operates production facilities in Kurgan and Zelenograd, producing pharmaceutical medications including essential drugs, with a strategic goal to increase domestic production share to 50% by 2030. The company also offers contract manufacturing, licensing production, and private label (STM) projects for pharmacy chains.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Product Portfolio Branded portfolio of pharmaceutical preparations including 12+ marketed medications and 23+ vital essential medicines, sold to pharmacy chains, healthcare institutions, and distributors across Russia.
• Contract Manufacturing Services B2B contract and license manufacturing of pharmaceutical products using the group's production facilities, offered to pharmaceutical partners.
• Private Label (СТМ) Production for Pharmacy Chains Private label (СТМ) manufacturing projects implemented for retail pharmacy chains, enabling pharmacy networks to offer their own branded pharmaceutical preparations produced by Velpharm Group.
• Velpharm-M Manufacturing Plant (Zelenograd) Newly opened pharmaceutical production plant 'Велфарм•М' (Velpharm-M) operating as the group's manufacturing subsidiary for the production of medicinal products.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Pharmacy Chains (Аптечные сети)coreChannel Partner/ Reseller/ DistributorVelpharm Group implements private label (СТМ) projects for pharmacy chains, offering contract manufacturing and licensing production services. This enables pharmacy networks to offer their own branded pharmaceutical products manufactured by Velpharm.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• R-Pharm: Major Russian pharmaceutical manufacturer with branded generics, hospital, and contract manufacturing operations. Directly comparable to Velpharm in product category, B2B channels, and alignment with state domestic production policies.
• Pharmasyntez: Russian finished-dose pharmaceutical manufacturer serving pharmacy chains and hospitals with a broad generic portfolio. Directly comparable to Velpharm's manufacturing model and domestic-market focus.
• Biocad: Russian biopharmaceutical company producing both biologics and small-molecule generics with significant government backing. Comparable to Velpharm as a domestic manufacturer aligned with Russian pharmaceutical sovereignty goals.
• GEROPHARM: Russian pharmaceutical company producing finished-dose generics and biologics with strong domestic market presence. Comparable to Velpharm as a domestic finished-dose manufacturer with government-aligned priorities.
• Valenta Pharm: Russian pharmaceutical manufacturer with a broad branded generic and OTC portfolio sold primarily through pharmacy chains. Directly comparable to Velpharm in target customer base and finished-dose offering.
• Pharmstandard (Фармстандарт): One of Russia's largest pharmaceutical manufacturers producing branded and generic preparations for primary care and hospital use. Directly comparable to Velpharm as a domestic finished-dose manufacturer targeting the same pharmacy chains and state-aligned import substitution agenda.
• Obnovlenie (Renewal): Russian generic pharmaceutical manufacturer with a large SKU catalog distributed via pharmacy chains. Directly comparable to Velpharm in product type, scale, and reliance on the domestic pharmacy retail channel.
• Polysan: Russian pharmaceutical manufacturer of branded generics and original products sold through pharmacy chains. Directly comparable to Velpharm in product category and B2B pharmacy channel.

Broad incumbents

• KRKA: European generic pharmaceutical manufacturer with strong Eastern European and CIS market presence. Comparable to Velpharm in generic finished-dose manufacturing and in competing for CIS/Russian pharmacy chain demand.
• Teva Pharmaceutical Industries: Global leader in generic pharmaceuticals with broad finished-dose manufacturing capabilities. Comparable to Velpharm at a category level (generic finished-dose manufacturing), though operating at vastly greater scale and global geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bright-way-group

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bright Way Group